Signaturefd, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Signaturefd, LLC
- $5.21 Billion
- Q4 2024
A detailed history of Signaturefd, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 2,028 shares of REGN stock, worth $1.37 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,028
Previous 2,365
14.25%
Holding current value
$1.37 Million
Previous $2.49 Million
41.91%
% of portfolio
0.03%
Previous 0.05%
Shares
28 transactions
Others Institutions Holding REGN
# of Institutions
1,487Shares Held
83.4MCall Options Held
1.32MPut Options Held
1.52M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.26 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.7 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.76 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.31 Billion0.21% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.19 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $72.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...